77 Canada Pharmacy World: Your Online Medication and Supplements Guide - Page 2
Euglycemic DKA on SGLT2 Inhibitors: How to Recognize and Treat This Hidden Emergency
Euglycemic DKA is a dangerous form of diabetic ketoacidosis that occurs with normal blood sugar levels, often in patients taking SGLT2 inhibitors like Farxiga or Jardiance. It's easily missed but can be fatal without prompt recognition and treatment.
China and India Manufacturing: Risks and FDA Monitoring in Pharmaceutical Supply Chains
China and India dominate global pharmaceutical manufacturing, but FDA monitoring reveals stark differences in compliance. India leads in regulatory reliability, while China offers scale at higher risk. Here's what you need to know about drug safety and supply chain risks.
How to Identify Counterfeit Medication Packaging and Seals
Learn how to spot fake medication packaging and seals with simple, practical checks anyone can do. From color mismatches to QR code scams, this guide helps you protect yourself from dangerous counterfeit drugs.
Medicaid Generic Drug Policies: How States Are Cutting Prescription Costs
States are using MAC lists, mandatory substitution, and price gouging laws to control Medicaid generic drug costs. With generics making up 85% of prescriptions but only 16% of spending, these policies save billions - but supply chain risks and PBM opacity threaten their success.
Insurance Benefit Design: How Health Plans Use Generics to Cut Costs
Health plans use tiered formularies, mandatory substitution, and step therapy to steer patients toward generic drugs, saving billions annually. But hidden pricing practices by pharmacy benefit managers often prevent patients from seeing the full savings.
QT Prolongation with Fluoroquinolones and Macrolides: Monitoring Strategies
Fluoroquinolones and macrolides can prolong the QT interval, increasing the risk of dangerous heart rhythms. Learn how to identify at-risk patients, when to order ECGs, and how to prevent life-threatening arrhythmias.
Hatch-Waxman Act: How It Shaped Generic Drug Access in the U.S.
The Hatch-Waxman Act revolutionized U.S. generic drug approval by balancing innovation and competition. It cut costs, sped up access, but also opened doors to patent abuse. Here’s how it works-and why it’s under pressure.
Influenza vs. COVID-19: Testing, Treatment, and Isolation Guidance for 2025
In 2025, influenza surpassed COVID-19 in hospitalizations and deaths. Learn how to tell them apart, when to test, which treatments work, and how long to isolate based on the latest CDC and clinical data.
Drug Recall Authority: How the FDA Legally Removes Unsafe Medications
The FDA can't force drug recalls - it can only request them. Learn how unsafe medications are removed from the market, the three recall classes, why devices are treated differently, and why experts are pushing for legal change.
How to Time Your Medications to Avoid Dangerous Drug Interactions
Learn how to time your medications correctly to avoid dangerous drug interactions. Simple changes like waiting 2-4 hours between certain pills can boost effectiveness and prevent side effects-without switching drugs.
Behavioral Economics: Why Patients Choose Certain Drugs (Even When It Doesn’t Make Sense)
Behavioral economics explains why patients often choose expensive drugs over cheaper, equally effective options. Learn how biases like loss aversion and present bias shape medication decisions - and how simple nudges can improve adherence.
Weight Loss Medications: GLP-1 Agonists vs. Older Drugs - What Actually Works
GLP-1 agonists like Wegovy and Zepbound offer far greater weight loss than older drugs like orlistat or phentermine, but they come with high costs, side effects, and insurance hurdles. Here's how they really compare.